Immunic (IMUX) Share-based Compensation Growth (5y) (2018 - 2026)
Immunic (IMUX) Share-based Compensation Growth (5y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Immunic |
384.84 Mn |
198.21 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
23.11% |
| Dec 31, 2025 |
-0.15% |
| Sep 30, 2025 |
51.49% |
| Jun 30, 2025 |
33.34% |
| Mar 31, 2025 |
42.05% |
| Dec 31, 2024 |
19.41% |
| Sep 30, 2024 |
619.49% |
| Jun 30, 2024 |
153.58% |
| Mar 31, 2023 |
85.96% |
| Dec 31, 2022 |
49.09% |
| Sep 30, 2022 |
658.96% |
| Jun 30, 2022 |
383.67% |
| Dec 31, 2021 |
26.34% |
| Sep 30, 2021 |
341.27% |
| Jun 30, 2021 |
592.02% |
| Mar 31, 2021 |
9.61% |
| Dec 31, 2020 |
19.61% |
| Sep 30, 2020 |
285.95% |
| Jun 30, 2020 |
509.88% |
| Mar 31, 2020 |
-15.16% |
